HIV neutralizing antibodies: clinical correlates and implications for vaccines.
about
Neutralizing antibodies and control of HIV: moves and countermoves.An Outdated Notion of Antibody Specificity is One of the Major Detrimental Assumptions of the Structure-Based Reverse Vaccinology Paradigm, Which Prevented It from Helping to Develop an Effective HIV-1 Vaccine.Activation-induced Markers Detect Vaccine-Specific CD4⁺ T Cell Responses Not Measured by Assays Conventionally Used in Clinical TrialsHigh-Frequency, Functional HIV-Specific T-Follicular Helper and Regulatory Cells Are Present Within Germinal Centers in Children but Not Adults
P2860
HIV neutralizing antibodies: clinical correlates and implications for vaccines.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
HIV neutralizing antibodies: clinical correlates and implications for vaccines.
@ast
HIV neutralizing antibodies: clinical correlates and implications for vaccines.
@en
type
label
HIV neutralizing antibodies: clinical correlates and implications for vaccines.
@ast
HIV neutralizing antibodies: clinical correlates and implications for vaccines.
@en
prefLabel
HIV neutralizing antibodies: clinical correlates and implications for vaccines.
@ast
HIV neutralizing antibodies: clinical correlates and implications for vaccines.
@en
P2860
P356
P1476
HIV neutralizing antibodies: clinical correlates and implications for vaccines.
@en
P2093
Nicole A Doria-Rose
P2860
P304
P356
10.1086/651143
P407
P577
2010-04-01T00:00:00Z